logo

For the Inventor, By the Inventor

Audubon, PA, United States of America

Kim-Anh Thi Doan

This inventor holds 5 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignees: Aventis Pharmaceuticals Inc., University of Pennsylvania. Active years: 2002-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kim-Anh Thi Doan. Retrieved from https://idiyas.com/inventor/kim-anh-thi-doan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 60.0


Average Co-Inventor Count = 6.4

ph-index = 3

Forward Citations = 18(Granted Patents)


Location History:

  • Spring City, PA (US) (2006)
  • Audubon, PA (US) (2002 - 2013)

Company Filing History:

goldMedal5 out of 207 
 
Aventis Pharmaceuticals Inc.
 patents
silverMedal1 out of 2,659 
 
University of Pennsylvania
 patents
where one patent can have more than one assignee

Years Active: 2002-2013

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents
1. 8343494 - Antibodies against LLG polypeptides of the triacylglycerol lipase family (2013-01-01),
2. 7579447 - Antibodies against LLG polypeptides of the triacylglycerol lipase family (2009-08-25),
3. 7056720 - LLG polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies (2006-06-06),
4. 7008776 - Compositions and methods for effecting the levels of high density lipoprotein (HDL) cholesterol and apolipoprotein AI very low density lipoprotein (VLDL) cholesterol and low density lipoprotein (LDL) cholesterol (2006-03-07),
5. 6395530 - LLG polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies (2002-05-28),

Title: Kim-Anh Thi Doan: Innovator in Lipid Metabolism Research

Introduction

Kim-Anh Thi Doan is a prominent inventor based in Audubon, PA (US), known for her significant contributions to the field of lipid metabolism. With a total of five patents to her name, she has made remarkable strides in understanding and treating disorders related to lipid metabolism.

Latest Patents

Her latest patents focus on antibodies against LLG polypeptides of the triacylglycerol lipase family, specifically Lipoprotein Lipase-like polypeptides. These patents disclose nucleic acids encoding said polypeptides, antisense sequences, and antibodies to these polypeptides. Additionally, she has developed methods for the preparation of these polypeptides in a recombinant system. Her work also includes the use of these polypeptides to screen for agonists and antagonists, as well as methods and compositions for treating disorders of lipid metabolism.

Career Highlights

Throughout her career, Kim-Anh has worked with notable organizations such as Aventis Pharmaceuticals Inc. and the University of Pennsylvania. Her experience in these institutions has allowed her to advance her research and contribute to the scientific community significantly.

Collaborations

Some of her notable coworkers include Michael C Jaye and John A Krawiec, who have collaborated with her on various projects related to her research.

Conclusion

Kim-Anh Thi Doan's innovative work in lipid metabolism research has led to significant advancements in the field. Her patents and collaborations reflect her dedication to improving health outcomes related to lipid disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…